Companies › LEGN

LEGEND BIOTECH CORP (LEGN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001801198 · EDGAR filings · Updated 2026-07-27

LEGEND BIOTECH CORP (LEGN) has reported institutional ownership of 26.0%, with 190 institutional managers holding positions valued at $1.74B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-27 — Foreign issuer report (6-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-15 — Foreign issuer report (6-K) filed
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-06-30 — Notice of proposed sale filed (Form 144)
• 2026-06-29 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, LEGEND BIOTECH CORP has 190 institutional holders and institutional ownership of 26.0%.

Insider activity

Insiders reported 1 transactions (0 buys, 1 sells) across 9 reporting insiders, with a net reported value of −$87.1K.

Data flags from SEC filings

Related companies

PEDIATRIX MEDICAL GROUP INC (MD) · ZYMEWORKS INC (ZYME) · INNOVIVA INC (INVA) · UFP TECHNOLOGIES INC (UFPT) · DR REDDYS LABS LTD (RDY) · PHARVARIS N V (PHVS)